As such, it is possible that cells downregulate ADAR1 with age to prevent excessive editing that may contribute to cancer development, which would be consistent with the idea of antagonistic pleiotropy as a key mechanism of aging (Austad and Hoffman, 2018). Here, ADAR is linked to cancer.